دورية أكاديمية
Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial.
العنوان: | Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial. |
---|---|
المؤلفون: | Blauvelt, Andrew, Langley, Richard G., Lacour, Jean-Philippe, Toth, Darryl, Laquer, Vivian, Beissert, Stefan, Wollenberg, Andreas, Herranz, Pedro, Pink, Andrew E., Peris, Ketty, Fangel, Stine, Gjerum, Le, Corriveau, Joshua, Saeki, Hidehisa, Warren, Richard B., Simpson, Eric, Reich, Kristian |
المصدر: | Journal of the American Academy of Dermatology; Oct2022, Vol. 87 Issue 4, p815-824, 10p |
مستخلص: | |
Copyright of Journal of the American Academy of Dermatology is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
قاعدة البيانات: | Supplemental Index |
كن أول من يترك تعليقا!